PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24155212-4	2014	The low expression of RRM1 and RRM2 significantly increased the platinum-based chemotherapy response (For RRM1: odds ratio (OR) = 2.09, 95% confidence interval (CI) = 1.38-3.18; For RRM2: OR = 1.64, 95% CI = 1.09-2.48).	Platinum	64-72	ribonucleotide reductase catalytic subunit M1	Homo sapiens	22-26	
24155212-4	2014	The low expression of RRM1 and RRM2 significantly increased the platinum-based chemotherapy response (For RRM1: odds ratio (OR) = 2.09, 95% confidence interval (CI) = 1.38-3.18; For RRM2: OR = 1.64, 95% CI = 1.09-2.48).	Platinum	64-72	ribonucleotide reductase catalytic subunit M1	Homo sapiens	106-110	
24155212-7	2014	In conclusion, low expression of RRM1 and RRM2 could be used to predict the treatment response to platinum-based chemotherapy and survival in NSCLC.	Platinum	98-106	ribonucleotide reductase catalytic subunit M1	Homo sapiens	33-37